Skip to content
Combined Shape Created with Sketch.
  • COVID-19
  • EyewireTV
  • Stocks
  • Interests
    • Cataract and Refractive Eye-Grey Created with Sketch.
    • Glaucoma Gauge-Grey Created with Sketch.
    • Healthcare Cross-Grey Created with Sketch.
    • Optometry Laser-Grey Created with Sketch.
    • Product Approvals Gear-Grey Created with Sketch.
    • Retina Laser-Grey Created with Sketch.
  • More
    • Events
    • Subscribe
    • About
    • Send a Tip
    • Advertising
    • Privacy Policy
  • COVID-19
  • EyewireTV
  • Stocks
  • Interests
    • Cataract and Refractive Eye-Grey Created with Sketch.
    • Glaucoma Gauge-Grey Created with Sketch.
    • Healthcare Cross-Grey Created with Sketch.
    • Optometry Laser-Grey Created with Sketch.
    • Product Approvals Gear-Grey Created with Sketch.
    • Retina Laser-Grey Created with Sketch.
  • Events
  • About
  • Send a Tip
  • Advertising
  • Privacy Policy

Johnson & Johnson

03.01.21

J&J’s COVID-19 Vaccine Wins FDA Authorization for Emergency Use

Source: FirstWord

02.24.21

One-Dose J&J COVID-19 Vaccine Meets Criteria as Safe and Effective, FDA Report Finds

Source: USA Today

02.24.21

Pfizer, Moderna and J&J Tout Supercharged COVID-19 Vaccine Output, Eyeing Nearly 140 Million New Doses by March

Source: FiercePharma

02.17.21

J&J Submits Single-Dose COVID-19 Vaccine for EMA Review

Source: FirstWord

02.05.21

J&J Files Single-Dose COVID-19 Vaccine for US Emergency Use

Source: FirstWord

01.29.21

J&J’s Single-Dose COVID-19 Vaccine 66% Effective

Source: FirstWord

01.14.21

Early Study Shows J&J’s One-Dose COVID-19 Vaccine Triggered Antibodies in all Participants

Source: FirstWord

12.17.20

Vaccine Rollout On Track, Expect 300M Doses Through March: Feds

Source: Medscape

11.16.20

Late-Breaking 12-Month Data of Investigational RPGR Gene Therapy Shows Statistically Significant and Continued Vision Improvement in Patients with XLRP

10.26.20

AstraZeneca, J&J Say Their COVID-19 Vaccine Trials Back on Track in US

Source: FirstWord

View more stories

Home

Menu

Share

  • Cataract and Refractive
  • Cornea
  • Glaucoma
  • Healthcare
  • Innovation
  • Optometry
  • Product Approvals
  • Retina
  • Events
  • About
  • Send a Tip
  • Advertising
  • Contact
  • EyewireTV
  • Stocks
  • Privacy Policy
Created with Sketch. Created with Sketch. Created with Sketch. Created with Sketch.
eyewire-news-color bmc-mark Created with Sketch.

© 2021 Bryn Mawr Communications, LLC.

All Rights Reserved.